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The present study was performed by using selective inhibitors of caspase-8 and caspase-3 
functioning upstream and downstream from mitochondria, respectively to determine 
whether mitochondria are involved in the mechanisms underlying production and exter-
nalization of oxidized phosphatidylserine (PSox) during Fas-mediated apoptosis. Treat-
ment with anti-Fas antibody induced caspase-3 activation, chromatin condensation, release 
of cytochrome c (cyt c) from mitochondria into the cytosol as well as production of PSox 
and its exposure to the cell surface in Jurkat cells. Inhibition of caspase-8 by pretreat-
ment with Z-IETD-FMK, a membrane permeable selective caspase-8 inhibitor reduced 
mitochondrial cyt c release, the amount of PSox not only within but also on the surface of 
Jurkat cells, caspase-3 activation, and apoptotic cell number after treatment with anti-Fas 
antibody. In contrast, Z-DEVD-FMK, a membrane permeable selective caspase-3 inhibi-
tor was unable to inhibit cyt c release, and the amount of PSox both within and on the 
surface of the cells after anti-Fas antibody, although it suppressed caspase-3 activation and 
apoptosis. Thus, these results strongly suggest that mitochondria play an important role in 
production of PSox and subsequent its externalization during apoptosis.
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Phospholipids in plasma membrane are distributed 
asymmetrically between two leaflets (Bretscher, 
1972), and the choline-containing phospholipids, 
phosphatidylcholine and sphingomyelin, reside 
mainly in the outer (extracellular) leaflet, whereas 
the aminophospholipids, phosphatidylserine (PS) 
and, to a lesser extent, phosphatidylethanolamine 
(PE), are confined to the inner (cytosolic) leaf-
let (Verkleij and Post, 2000). This asymmetry is 
considered to be established and maintained by at 
least three lipid translocators: i) ATP-dependent 
flippases, members of type 4 P-type ATPases, also 
referred to as aminophospholipid translocases, 
that are specific for aminophospholipids, with a 
preference for PS over PE, and catalyze the inward 
translocation of aminophospholipids (Folmer et 
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al., 2009); ii) another ATP-dependent translocator 
floppases, members of ATP-binding cassette trans-
porters, which catalyze the efflux of phospholipids 
from the inner to the outer leaflet with little selec-
tivity for polar head group of the phospholipids 
(Contreras et al., 2010) and iii) energy-independent 
scramblases that are non-selective and catalyze 
bidirectional transbilayer movement of phospho-
lipids Ca2+-dependently but ATP-independently 
(Bevers and Williamson, 2010). It is generally ac-
cepted that PS predominantly localized in the inner 
leaflet migrates to the outer leaflet of the plasma 
membrane during apoptosis, and is recognized by 
macrophages as an “eat-me” signal, resulting in 
successful clearance of apoptotic cells (Verhoven et 
al., 1995). This PS egress during apoptosis seems 
to be associated with the inhibition of flippases as 
well as the activation of scramblases in the plasma 
membrane (Fadeel et al, 2010).
 The generation of reactive oxygen species 
(ROS) and subsequent oxidative stress are com-
monly involved in the initiation and/or the execu-
tion phases of apoptosis (Banki et al., 1999; Li et 
al., 1999). Mitochondrial permeability transition 
and the release of cytochrome c (cyt c) from mito-
chodria into the cytosol during apoptosis are related 
to excessive ROS generation (Cai and Jones, 1998; 
Matsura et al., 2005). Recent studies have reported 
almost simultaneous oxidation and externalization 
of an anionic phospholipid PS during apoptosis 
(Matsura et al., 2003; Kagan et al., 2004). Selective 
oxidation of another anionic phospholipids such as 
cardiolipin (CL) and phosphatidylinositol (PI) has 
also been induced during apoptosis (Matsura et al., 
2003; Kagan et al., 2004; Matsura et al., 2005).
 We revealed that H2O2 is important not only 
for PS oxidation but also for its externalization dur-
ing apoptosis using catalase overexpressing HP100 
cells (Matsura et al., 2004). We also found that 
there is oxidized PS (PSox) both within and on the 
surface of Jurkat cells undergoing apoptosis after 
treatment with anti-Fas antibody (Matsura et al., 
2005).
 It has been suggested that peroxidase activ-
ity of cyt c is closely related to PS oxidation and 
externalization (Kagan et al., 2004). Therefore, we 
determined whether departure of cyt c from mito-
chondria is required for production of PSox as well 
as its externalization during apoptosis using two 
selective caspase inhibitors functioning upstream 







Fluorescamine was purchased from Sigma Chemi-
cal (St. Louis, MO). Anti-Fas antibody (Clone CH-
11) was purchased from Medical and Biological 
Laboratories (Nagoya, Japan). Fetal calf serum 
(FCS) was purchased from PAA Laboratories 
GmbH (Linz, Austria). Membrane-permeable cas-
pase-8 inhibitor (Z-IETD-FMK) and caspase-3 in-
hibitor (Z-DEVD-FMK) were purchased from R & 
D Systems (Minneapolis, MN). Methanol (HPLC-
grade), acetone (HPLC-grade), acetic acid, iodine, 
ninhydrin spray, butylated hydroxytoluene (BHT) 
and N,N,N',N'-tetramethyl-p-phenylenediamine di-
hydrochloride (TMPD) were obtained from Wako 
Pure Chemical Industries (Osaka, Japan). Chlo-
roform (HPLC-grade) was purchased from Kanto 
Kagaku (Tokyo, Japan). 7-Amino-4-methyl-cou-
marin (AMC) and acetyl-Asp-Glu-Val-Asp-AMC 
(Ac-DEVD-AMC) were purchased from Peptide 
Institute (Osaka, Japan). RPMI 1640 medium 
with phenol red was obtained from Nissui Phar-
maceutical (Tokyo). RPMI 1640 medium without 
phenol red was obtained from Cosmo Bio (Tokyo). 
Hoechst 33342 was purchased from Molecular 
Probes (Eugene, OR). High-performance thin-layer 
chromatography (HPTLC) plates (10 × 10 cm, 
Silica Gel 60) were obtained from Merck (Darm-
stadt, Germany). 1-Oleoyl-2-hydroxy-sn-glycero-3- 
phosphoethanolamine (LPE) was purchased from 
Avanti Polar Lipids (Alabaster, AL). 1-Stearoyl-
2-arachidonylglycerol hydroperoxide (SAGOOH) 
was synthesized as described previously (Takekoshi 









Jurkat T cell line was obtained from Riken Cell 
Bank (Tsukuba, Japan), and grown in RPMI 1640 
medium supplemented with 10% heat-inactivated 
FCS, 2 mM glutamine and antibiotics (100 units/
mL penicillin, 100 µg/mL streptomycin) at 37 ˚C 
in a humidified incubator with 5% CO2. All the ex-
periments were performed using RPMI 1640 me-
dium containing 10% FCS. Cells were seeded at a 
concentration of 2 × 105 cells/mL and logarithmic 
growth was maintained by passaging every 2 or 3 
days. 
 
Determination of apoptotic cells
 
Apoptotic cells were assessed by nuclear morphol-
ogy as described previously (Matsura et al., 2002, 
2004). Jurkat cells (1.0 × 106 cells/mL) were in-
cubated with anti-Fas antibody at 37 ˚C, washed 
with phosphate-buffered saline (PBS), and then 
fixed with 1% glutaraldehyde overnight. Samples 
were centrifuged, resuspended in PBS, stained 
with Hoechst 33342 (1 mM), and then mounted on 
a glass slide, and observed under fluorescence mi-
croscope. Results were expressed as the percentage 
of the cells showing characteristic nuclear morpho-
logical features of apoptosis (nuclear condensation 
and fragmentation) relative to the total number of 
counted cells (≥ 200 cells per each point).
  
Measurement of caspase-3 activity
 
The activity of caspase-3 was determined as de-
scribed previously (Matsura et al., 2002, 2004). 
Briefly, after treatment of Jurkat cells (1 × 106 cells/
mL) with anti-Fas antibody (200 ng/mL), cells were 
collected, washed in PBS, and lysed for 20 min 
on ice in lysis buffer containing 10 mM HEPES-
KOH (pH 7.4), 2 mM EDTA, 0.1% 3-[(3-cholami-
dopropyl)dimethylammonio]-1-propane sulfonate) 
(CHAPS), 1 mM phenylmethyl-sulfonyl fluoride 
(PMSF) and 5 mM dithiothreitol (DTT). The sus-
pensions were centrifuged at 4 ˚C and the superna-
tants were collected as lysates. For measurement 
of caspase activity, 10 µg of lysate diluted to 20 µL 
with lysis buffer was mixed with 20 µL of 2 × ICE 
buffer containing 40 mM HEPES-KOH (pH 7.4), 
20% (v/v) glycerol, 1 mM PMSF and 4 mM DTT 
supplemented with 40 µM Ac-DEVD-AMC (a 
fluorogenic peptide substrate) and incubated for 60 
min at 37 ˚C. After 60 min, 160 µL of distilled wa-
ter was added and the fluorescence was measured 
in a CytoFluor II (Applied Biosystems, Foster City, 
CA) fluorescence microplate reader using excitation 
at 360 ± 40 nm and emission at 460 ± 40 nm. One 
unit of caspase activity was defined as the amount 
of enzyme required to release 1 pmol AMC per 
minute at 37 ˚C.
 The protein concentration of cell lysates was 
measured by the method of Bradford (Bradford, 
1976).
  
Flow cytometry of PS externalization
 
Annexin V binding to cells was determined using 
a commercially available Annexin V-FITC Apop-
tosis Detection Kit (Medical & Biological Labora-
tories, Nagoya, Japan) and flow cytometry as previ-
ously described (Matsura et al., 2005). Briefly, after 
treatment of cells (1 × 106 cells/mL) with anti-Fas 
antibody, cells were recovered and washed once 
with pre-warmed RPMI 1640 medium without 
phenol red. Cells were incubated with fluorescein 
isothiocyanate-conjugated annexin V (0.5 µg/mL) 
for 5 min and then were collected by centrifugation 
and washed with binding buffer. Propidium iodide 
(0.6 µg/mL) was added, and cells were immediately 
analyzed with an Epics cytofluorometer (Beckman 
Coulter, Fullerton, CA). 
  
Determination of cyt c release
 
Jurkat cells were treated with 200 ng/mL anti-Fas 
antibody, harvested and washed three times with 
ice-cold PBS. Cells were resuspended in isotonic 
buffer containing 10 mM HEPES, 0.3 M mannitol, 
0.1% bovine serum albumin, 5 mM EDTA and 1 
mM PMSF supplemented with 0.1 mM digitonin 
(5 × 107 cells/mL), left on ice for 5 min and imme-
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diately centrifuged at 8,500 × g for 5 min at 4 ˚C. 
The supernatant collected was used as the cytosolic 
fraction. The cyt c amount in the cytosolic fraction 
was measured by Western blotting using cyt c (6H2) 
monoclonal antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA) (1:1000) as described previously 
(Matsura et al., 2005). The densitometric quantita-
tive analysis was performed by using NIH Image.
Fluorescamine labeling of externalized ami-
nophospholipids and measurement of phos-
phorus
 
Labeling of externalized aminophospholipids, 
PS and PE with membrane-impermeable fluores-
camine, a probe for visualizing lipids that contain 
primary amino groups, was carried out by methods 
previously described (Matsura et al., 2005). Briefly, 
Jurkat cells (1 × 106 cells/mL) treated with anti-
Fas antibody (200 ng/mL) for 8 h at 37 ˚C were 
suspended in labeling buffer (150 mM NaCl, 5 mM 
KCl, 1 mM MgCl2, 1 mM CaCl2, 5 mM NaHCO3, 
5 mM glucose, and 20 mM HEPES/KOH, pH 8.0). 
Cells were gently agitated in the presence of fluo-
rescamine (200 mM) for 30 s. The reaction was 
stopped by the addition of 40 mM Tris-HCl, pH 7.5. 
Cells were counted again and collected by centrifu-
gation, and lipids in 8 × 107 cells were extracted 
by the Folch procedure (Folch et al., 1957) and 
analyzed by HPTLC. To protect lipids from autoxi-
dation during the extraction procedure, the anti-
oxidant BHT (1.3 mM) was added to each sample. 
Aliquots of the cells (1 × 107) were stored at –80 
˚C until phosphorus measurement. The phosphorus 
content of lipids was determined by the method 
of Chalvardjian and Rudnicki (Chalvardjian and 
Rudnicki, 1970).
  
Detection of externalized and oxidized PS 
by HPTLC
 
Externalized and oxidized PS was determined as 
described previously (Matsura et al., 2005). Briefly, 
lipid extracts redissolved in chloroform:methanol 
(2:1, v/v) were applied to the HPTLC plate under an 
N2 stream. The phospholipid classes in the extracts 
were analyzed by two-dimensional HPTLC us-
ing a solvent system of chloroform:methanol:water 
(55:35:4, v/v/v) in the first direction and chloroform
:acetone:methanol:acetic acid:water (50:20:10:10:5, 
v/v/v/v/v) in the second. The phospholipids were 
visualized by exposure to iodine vapor. The iden-
tity of each phospholipid was established by com-
parison with the Rf values of authentic standards 
(Phospholipid Kit; DOOSAN Serdary Research 
Laboratories, Yongin City, Korea). Fluorescamine-
modified PS and PE were localized by exposure of 
HPTLC plates to UV light with a Gel Doc 2000 
(Bio-Rad Laboratories, Hercules, CA). LPE (2 
nmol) was used as an internal standard for fluores-
camine-modified phospholipids. We photographed 
the plate, scanned PS, PE and LPE modified by flu-
orescamine (referred to as mPS, mPE and mLPE, 
respectively) in control and anti-Fas antibody-
treated cells, and quantified the ratios mPS/mLPE 
in both cells by using NIH Image. In addition, we 
measured the phosphorus content in the total lipids 
extracted from both control and Fas-ligated cells 
(8 × 107 cells) and expressed the content of mPS as 
the following relative density: 104 × mPS/mLPE/
phosphorus of 8 × 107 cells.
 To determine PSox on the cell surface, colo-
rimetric spray detection with TMPD was carried 
out (Matsura et al., 2005). After chromatography, 
the plate was dried under an N2 stream and sprayed 
immediately with freshly prepared 1% (w/v) TMPD 
in methanol:water:acetic acid (50:50:1, v/v/v). Syn-
thetic SAGOOH was used as an external standard 
as described previously (Matsura et al., 2005). We 
quantified the ratio of TMPD-visualized phospho-
lipid/TMPD-visualized SAGOOH in control and 
anti-Fas antibody-treated cells by using NIH Image 
and expressed the content as the following relative 
density: 104 × TMPD-visualized phospholipid/
TMPD-visualized SAGOOH/phosphorus of 8 × 
107 cells. Then, the same plate was subjected to 
UV light exposure to determine whether the PSox 
was externalized. Thereafter, the content of PSox 
exposed on the cell surface was expressed as the 
following relative ratio: (TMPD-visualized mPS/
15
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TMPD-visualized SAGOOH)/(mPS/mLPE). Ad-
ditionally, to determine unmodified PS, i.e., PS 
within the cells, the same plate was sprayed with 





Data were expressed as mean ± SE. Changes in 
variables for different assays were analyzed either 
by Student’s t test (single comparisons) or by one-
way ANOVA for multiple comparisons. Differ-




Inhibition by caspase inhibitors of Fas-
mediated apoptosis and caspase-3 activation
 
According to the results of our previous experi-
ments (Matsura et al., 2005), we induced apoptosis 
by treatment of Jurkat cells with 200 ng/mL anti-
Fas antibody for 8 h at 37 ˚C. To determine the 
concentration of caspase inhibitors required to 
inhibit Fas-mediated apoptosis in Jurkat cells, we 
treated the cells with Z-IETD-FMK, a membrane-
permeable caspase-8 inhibitor, or Z-DEVD-FMK, 
a membrane-permeable caspase-3 inhibitor at 
concentrations ranging from 0.5 to 5 µM 30 min 
before addition of anti-Fas antibody. Z-IETD-FMK 
inhibited Fas-mediated apoptosis in a dose depen-
dent manner, and the numbers of apoptotic cells 
were significantly reduced to 14% of cells exposed 
to anti-Fas antibody alone by treatment with 5 µM 
Z-IETD-FMK (Fig. 1A). Pretreatment of the cells 
with Z-IETD-FMK also inhibited Fas-mediated 
caspase-3 activation dose-dependently (Fig. 1B). 
Treatment with 5 µM Z-IETD-FMK significantly 
inhibited caspase-3 activity by 46% compared with 
anti-Fas antibody alone (Fig. 1B). Z-DEVD-FMK 
pretreatment similarly inhibited Fas-mediated 
apoptosis in a dose-dependent manner. Treatment 
with 5 µM of Z-DEVD-FMK suppressed apoptotic 
cell number (Fig. 2A) and caspase-3 activity (Fig. 
2B) by 87% and 54%, respectively, compared with 
anti-Fas antibody alone.
 Given these results, we used 5 µM as the con-
centration of caspase inhibitors in the following 
experiments.
  
Effect of caspase inhibitors on PS external-
ization in Jurkat cells following Fas ligation
 
We next examined whether there is difference in 
the effect of caspase-8 inhibitor and caspase-3 in-
hibitor functioning upstream and downstream from 
mitochondria, respectively, on PS externalization 
during Fas-mediated apoptosis. As shown in Fig. 3, 
Fig. 1. Effect of caspase-8 inhibitor on Fas-mediated 
apoptosis and caspase-3 activation in Jurkat cells. Cells 
were incubated with anti-Fas antibody (200 ng/mL) in 
10% fetal calf serum containing RPMI 1640 for 8 h at 37 
˚C under a 5% CO2/95% air atmosphere. Z-IETD-FMK, 
a caspase-8 inhibitor at the indicated concentrations was 
added 30 min before anti-Fas antibody treatment. The 
ratio of apoptotic cells (A) was determined by examin-
ing nuclear morphology after Hoechst 33342 staining. 
Caspase-3 activities (B) were measured with a fluorescent 
substrate as described in Materials and Methods. Data 
points represent the means ± SE (n = 3). *P < 0.01 versus 
control, †P < 0.01 versus anti-Fas antibody alone. 
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Fig. 2. Effect of caspase-3 inhibitor on Fas-mediated 
apoptosis and caspase-3 activation in Jurkat cells. Cells 
were incubated with anti-Fas antibody (200 ng/mL) as 
described in the legend to Fig. 1. Z-DEVD-FMK, a cas-
pase-3 inhibitor at the indicated concentrations was added 
30 min before anti-Fas antibody treatment. The ratio of 
apoptotic cells (A) was determined by examining nuclear 
morphology after Hoechst 33342 staining. Caspase-3 ac-
tivities (B) were measured with a fluorescent substrate as 
described in Materials and Methods. Data points represent 
the means ± SE (n = 3). *P < 0.01 versus control, †P < 0.01 
versus anti-Fas antibody alone.
Fig. 3. Effect of caspase inhibitors on phosphatidylserine 
(PS) exposure to the surface of Jurkat cells after treatment 
with anti-Fas antibody. Cells were incubated with anti-Fas 
antibody (200 ng/mL) as described in the legend to Fig. 
1. Z-IETD-FMK (5 µM) or Z-DEVD-FMK (5 µM) was 
added 30 min before anti-Fas antibody treatment. At the 
end of incubation, cells were collected and PS externaliza-
tion was determined by flow cytometry with an Annexin 
V-FITC Apoptosis Detection Kit as described in Materi-
als and Methods. Data points represent the means ± SE 
(n = 3). *P < 0.01 versus control, †P <0.01 versus anti-Fas 
antibody alone (black column). 
Z-IETD-FMK inhibited PS externalization in Jur-
kat cells after Fas ligation by 40%. In contrast, Z-




Effect of caspase inhibitors on release of 
mitochondrial cytochrome c in Jurkat cells 
following Fas ligation
 
To examine effect of caspase inhibitors on the re-
lease of cyt c from mitochondria into the cytosol, 
we measured cyt c in the cytosol of Jurkat cells at 8 
h after treatment with anti-Fas antibody by Western 
blotting. Z-IETD-FMK prevented the efflux of cyt 
c from mitochondria into the cytosol during Fas-
mediated apoptosis in Jurkat cells (Fig. 4). How-
ever, Z-DEVD-FMK was unable to suppress Fas-




Effect of caspase inhibitors on the amount 
of PSox transmigrated to the cell surface 
during Fas-mediated apoptosis
 
As reported previously (Matsura et al., 2005), we 
developed the fluorescamine-TMPD method to 
detect PSox externalized after Fas ligation using 
two probes on HPTLC chromatogram: TMPD for 
phospholipid hydroperoxides and fluorescamine 
for external aminophospholipids. The amount of 
externalized PS, i.e., mPS increased after treat-
ment of the cells with anti-Fas antibody (200 ng/
mL) for 8 h (Fig. 5A). TMPD-visualized mPS, i.e., 
oxidized mPS also increased after Fas ligation (Fig. 
5B). Z-IETD-FMK reduced both levels of mPS 
and oxidized mPS to control level (Figs. 5A and B). 
In contrast, Z-DEVD-FMK failed to suppress both 
levels (Figs. 5A and B). Semi-quantitatively, Fas 
ligation increased the amount of PSox on the cell 
surface 1.7 times compared with control (Fig. 5C). 
Z-IETD-FMK significantly decreased the amount 
by 38% (Fig. 5C). However, Z-DEVD-FMK did 
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Fig. 5. Effect of caspase inhibitors on oxidation of PS exposed to the surface of Jurkat cells after treatment with anti-Fas 
antibody. Cells were incubated with anti-Fas antibody (200 ng/mL) as described in the legend to Fig. 1. Z-IETD-FMK 
(5 µM) or Z-DEVD-FMK (5 µM) was added 30 min before anti-Fas antibody treatment. At the end of incubation, total 
lipids of cells were extracted after a short treatment with fluorescamine and subjected to HPTLC. 
A: Fluorescamine-modified PS and PE were localized by exposure of HPTLC plates to UV light. LPE was used as an 
internal standard. 
B: To determine PSox on the cell surface, colorimetric spray detection with TMPD was carried out as described in Ma-
terials and Methods. SAGOOH was used as an external standard as described in Materials and Methods. Represen-
tative data from three separate experiments are shown. 
C: The content of PSox exposed on the cell surface was shown as the relative ratio as described in Materials and Meth-
ods. Data points represent the means ± SE of 3 separate experiments. *P < 0.01 versus control, †P < 0.01 versus anti-
Fas antibody alone (black column). 
HPTLC, high-performance thin-layer chromatography; TMPD, N,N,N',N'-tetramethyl-p-phenylenediamine dihydro-
chloride.
not inhibit the increase in the amount (Fig. 5C). 
Furthermore, PS unmodified by fluorescamine, i.e., 
PS within the cells (referred to as PSin) was deter-
mined using ninhydrin staining. Although anti-Fas 
antibody treatment decreased PSin, Z-IETD-FMK 
but not Z-DEVD-FMK prevented the decrease 
in PSin after Fas ligation (data not shown). As 
mentioned above, the amount of PSin in the cells 
treated with anti-Fas antibody or anti-Fas antibody 
plus Z-DEVD-FMK was lesser than that in control 
cells or the cells treated with anti-Fas antibody plus 
Z-IETD-FMK. However, the degree of PSin oxida-
tion was stronger in the former cells (Fig. 5B). 
 LPE  lysoPE 
 mLPE  LPE modified by fluorescamine
 mPE  PE modified by fluorescamine
 mPS  PS modified by fluorescamine 
 NL  neutral lipid 
 PE  phosphatidylethanolamine 
 PI phosphatidylinositol
 PS  phosphatidylserine
 SAGOOH  1-stearoyl-2-arachidonylglycerol 
hydroperoxide
Fig. 4. Effect of caspase inhibitors on cytochrome c (cyt c) 
release into the cytosol in Jurkat cells after treatment with 
anti-Fas antibody. Cells were incubated with anti-Fas an-
tibody (200 ng/mL) as described in the legend 
to Fig. 1. Z-IETD-FMK (5 µM) or Z-DEVD-
FMK (5 µM) was added 30 min before anti-Fas 
antibody treatment. At the end of incubation, 
cytosolic fractions were prepared and analyzed 
for cyt c content by Western blotting as de-
scribed in Materials and Methods. The results 
of densitometric analysis are shown as fold in-
crease relative to control. Data points represent 
the means ± SE (n = 3). *P < 0.01 versus con-
trol, †P < 0.01 versus anti-Fas antibody alone 
(black column).
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In the present study, we demonstrated using selec-
tive inhibitors of caspase-8 and caspase-3 that mi-
tochondria play an important role in both produc-
tion and externalization of PSox during apoptosis.
 Caspases are a special family of proteases 
characterized by a cysteine in the catalytic site and 
an unusual cleavage specificity for aspartic acid 
residues (Grutter, 2000). To date the human cas-
pase family has 11 members, which are classified 
into two major subfamilies, the apoptotic and the 
inflammatory caspases (Siegel, 2006). The apop-
totic caspases are further divided into two classes, 
initiator and executioner caspases (Kantari and 
Walczak, 2011). Caspase-8 is an initiator caspase 
and caspase-3 is an executioner one.
 There are two signaling pathways for apopto-
sis, intrinsic (mitochondrial) and extrinsic (recep-
tor-mediated) pathways (Olsson and Zhivotovsky; 
2011). The intrinsic apoptosis induced by stresses 
such as DNA damages, ROS, ultraviolet and anti-
cancer drugs, involves disruption of mitochondrial 
integrity accompanied by the release of cyt c into 
the cytosol. In the cytosol, released cyt c binds to 
apoptotic protease-activating factor 1, ATP, and 
procaspase-9 to form the apoptosome and lead to 
activation of executioner caspases, which finally in-
duce cell death. In the extrinsic apoptosis, extracel-
lular cognate ligands (e.g., Fas ligand) or agonistic 
antibodies (e.g., anti-Fas antibody CH-11) stimulate 
oligomerization of receptor (e.g., Fas), the recruit-
ment of adaptor proteins (e.g., FADD) and initiator 
procaspase-8 molecules to the cytosolic side of 
the receptor to form the death-inducing signaling 
complex (DISC) (Shawgo et al., 2009). Within the 
DISC, procaspase-8 molecules are activated by 
dimerization and subsequently undergo auto-pro-
cessing. Active caspase-8 can directly activate the 
executioner caspase-3 (type I cells) or cleaves the 
cytosolic BH3-only protein Bid to truncated Bid 
(tBid) (type II cells). In turn, tBid translocates to the 
mitochondria and stimulates mitochondrial outer 
membrane permeabilization (MOMP), the release 
of intermembrane space proteins such as cyt c into 
the cytosol and apoptosome formation responsible 
for the activation of executioner caspases including 
caspase-3. Jurkat cells we used in this study belong 
to type II cells (Shawgo et al., 2009).
 Recent studies have suggested that peroxidase 
activity of cyt c is closely related to PS oxidation 
and externalization (Kagan et al., 2004; Byir et al., 
2006). Furthermore, it has been reported that PS 
oxidation in lung epithelial A549 cells undergoing 
apoptosis after Fas ligation was sensitive to a pan-
caspase inhibitor, Z-VAD, which inhibited cyt c 
efflux from mitochondria but was insensitive to 
a caspase-3 inhibitor, Z-DQMD, which failed to 
prevent mitochondrial disruption and cyt c release 
(Jiang et al., 2004). However, they did not examine 
the effect of caspase inhibitors on PSox external-
ization in their study.
 Previously we developed f luorescamine-
TMPD method to directly determine the presence 
of PSox on the surface of apoptotic cells (Matsura 
et al., 2005). This method is semiquantitative but 
can easily detect PS externalization and oxidation 
on the same HPTLC plate (i.e., PSox on the cell 
surface). Additionally, we can detect PSox within 
the cells on the same HPTLC plate by a combina-
tion of staining with ninhydrin, another probe that 
reacts with primary amino groups. We revealed 
by these methods that treatment of Jurkat cells 
with anti-Fas antibody increased PSox within the 
cells and caused PSox to appear on the cell surface 
(Matsura et al., 2005).
 To illustrate mitochondrial involvement in 
production and exposure of PSox, we examined by 
fluorescamine-TMPD method the effect of selective 
inhibitors of caspase-8 and caspase-3 on produc-
tion of PSox and its externalization during extrin-
sic type II cell apoptosis in the present study. As 
mentioned above, caspase-8 inhibitor can block the 
apoptotic signal from DISC to mitochondria. By 
contrast, caspase-3 inhibitor functions downstream 
from mitochondria (more precisely downstream of 
apoptosome formation) to suppress characteristic 
morphological and biochemical changes in apop-
tosis. Inhibition of caspase-8 by Z-IETD-FMK, a 
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membrane permeable selective caspase-8 inhibitor 
reduced mitochondrial cyt c release into the cyto-
sol, the amount of PSox not only within but also on 
the surface of type II Jurkat cells, caspase-3 activa-
tion, and apoptotic cell number after treatment with 
anti-Fas antibody (CH-11). In contrast, Z-DEVD-
FMK, a membrane permeable selective caspase-3 
inhibitor was unable to inhibit cyt c release, and 
the amount of PSox both within and on the surface 
of the cells after anti-Fas antibody as expected, 
although it suppressed activation of the executioner 
caspase-3 and apoptosis. These results strongly 
suggested that mitochondrial event, especially cyt c 
departure from mitochondria plays a critical role in 
production of PSox within the cells and subsequent 
its appearance on the cell surface during extrinsic 
apoptosis.
 It is considered that a potential mechanism 
underlying PSox production during apoptosis re-
lies on the specific interactions between positively 
charged cyt c and negatively charged phospholipids 
such as PS in the cytosolic leaflet of the plasma 
membrane and CL in the mitochondria (Kagan 
et al., 2004, 2009). As for CL, high-affinity bind-
ing of CL with cyt c—accompanied by unfold-
ing of the protein—is realized largely through an 
electrostatic interface between negatively charged 
phosphates on CL and positively charged lysines on 
cyt c, as well as through hydrophobic interactions 
of CL’s acyl groups with a hydrophobic domain of 
the protein (Kagan et al., 2009). PS may also bind 
and unfold cyt c via analogous mechanisms. It has 
been reported that the interaction of cyt c with CL 
causes a marked negative shift of cyt c’s redox po-
tential, thus precluding its operation as an electron 
acceptor from mitochondrial complex III (Kagan 
et al., 2009). It is proposed that cyt c in cyt c/CL 
complexes functions as peroxidase to oxidize CL in 
the presence of ROS (O2– and H2O2) produced by 
disrupted mitochondrial electron transport (Kagan 
et al., 2009; Hüttemann et al., 2011). Since cyt c 
has lower affinity for oxidized CL (CLox) than for 
CL, it gets detached from membranes. Thereafter, 
cyt c is released into the cytosol following stimula-
tion of MOMP by CLox (Kagan et al., 2009). cyt c 
released into the cytosol forms cyt c/PS complexes 
in the cytosolic leaflet of plasma membrane as 
mentioned above and probably oxidizes PS by its 
peroxidase activity (Matsura et al., 2003). We pre-
viously observed using HP100 cells overexpressing 
catalase derived from HL-60 cells that endogenous 
H2O2 is a key oxidant for cyt c release from mito-
chondria as well as PS oxidation during apoptosis 
(Matsura et al., 2004). Taken together, these find-
ings support strongly the notion that interaction of 
cyt c/anionic phospholipid (CL in mitochondria or 
PS in plasma membranes) complexes with H2O2 is 
important for PS oxidation via peroxidase activity 
of cyt c.
 In respect to externalization of PSox, recent 
report demonstrated that flippase can recognize 
PSox and PS as its substrates, and that PSox may 
act as a “non-enzymatic scramblase” and stimu-
late scrambling of PS and/or PSox (Tyurina et al., 
2004). However, its precise mechanisms remain to 
be elucidated. At least, it must be clarified how the 
affinity of membrane phospholipid translocators 
including flippases and scramblases for PSox is.
 In conclusion, the present study has shown 
that mitochondria play an essential role in produc-
tion of PSox and subsequent its transmigration 
to the cell surface during extrinsic apoptosis by 
blocking signal transduction from DISC upstream 
and downstream from mitochondria using selective 
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